XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 59 filers reported holding XENON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,444,000 | -44.8% | 94,488 | -32.8% | 0.52% | -43.5% |
| Q2 2021 | $2,617,000 | +1.5% | 140,551 | -2.5% | 0.93% | -15.7% |
| Q1 2021 | $2,579,000 | -16.2% | 144,101 | -27.9% | 1.10% | -20.8% |
| Q4 2020 | $3,076,000 | +57.0% | 200,000 | +13.0% | 1.39% | +21.1% |
| Q3 2020 | $1,959,000 | -7.6% | 177,000 | +4.7% | 1.15% | -0.7% |
| Q2 2020 | $2,119,000 | +6.6% | 169,000 | -3.5% | 1.16% | -7.7% |
| Q1 2020 | $1,987,000 | -22.5% | 175,204 | -10.5% | 1.25% | +20.6% |
| Q4 2019 | $2,565,000 | +52.0% | 195,657 | +4.5% | 1.04% | +46.7% |
| Q3 2019 | $1,688,000 | -4.6% | 187,311 | +4.4% | 0.71% | -5.0% |
| Q2 2019 | $1,769,000 | -3.0% | 179,390 | 0.0% | 0.75% | +2.6% |
| Q1 2019 | $1,823,000 | +66.6% | 179,390 | +3.5% | 0.73% | +41.4% |
| Q4 2018 | $1,094,000 | -52.2% | 173,390 | 0.0% | 0.51% | -30.8% |
| Q3 2018 | $2,289,000 | +43.5% | 173,390 | 0.0% | 0.74% | +24.2% |
| Q2 2018 | $1,595,000 | +183.3% | 173,390 | +50.9% | 0.60% | +157.8% |
| Q1 2018 | $563,000 | +111.7% | 114,900 | +22.2% | 0.23% | +118.9% |
| Q4 2017 | $266,000 | +100.0% | 94,000 | +108.9% | 0.11% | +86.0% |
| Q3 2017 | $133,000 | – | 45,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |